| Dr Maureen R Nelson, MD | |
|
8611 N Mopac Expy Ste 300, Austin, TX 78759-8319 | |
| (737) 220-8200 | |
| Not Available |
| Full Name | Dr Maureen R Nelson |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 8611 N Mopac Expy Ste 300, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801820170 | NPI | - | NPPES |
| 1317X | Other | NC | NCBCBS |
| 891317X | Medicaid | NC | |
| QH8772 | Medicaid | SC |
| Entity Name | Dell Childrens Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326072943 PECOS PAC ID: 8224092978 Enrollment ID: O20041112001030 |
News Archive
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
A scientific collaboration between Envigo and the Department of Infectious Disease at the University of Gothenburg, Sweden has unveiled study findings into rat models and their susceptibility to intra-vaginal herpes simplex virus-2 (HSV-2) infection.
› Verified 4 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
A scientific collaboration between Envigo and the Department of Infectious Disease at the University of Gothenburg, Sweden has unveiled study findings into rat models and their susceptibility to intra-vaginal herpes simplex virus-2 (HSV-2) infection.
› Verified 4 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285079764 PECOS PAC ID: 0648405738 Enrollment ID: O20131025000939 |
News Archive
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
A scientific collaboration between Envigo and the Department of Infectious Disease at the University of Gothenburg, Sweden has unveiled study findings into rat models and their susceptibility to intra-vaginal herpes simplex virus-2 (HSV-2) infection.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maureen R Nelson, MD 6621 Fannin St, Mc Wt 21-329, Houston, TX 77030-2358 Ph: (832) 824-1000 | Dr Maureen R Nelson, MD 8611 N Mopac Expy Ste 300, Austin, TX 78759-8319 Ph: (737) 220-8200 |
News Archive
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
A scientific collaboration between Envigo and the Department of Infectious Disease at the University of Gothenburg, Sweden has unveiled study findings into rat models and their susceptibility to intra-vaginal herpes simplex virus-2 (HSV-2) infection.
› Verified 4 days ago
Mrs. Kaycee Mcelwee, PT, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 706a W Ben White Blvd, Austin, TX 78704 Phone: 512-441-5100 Fax: 512-441-5108 | |
Enrique B Pena, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1004 W 32nd St Ste 200, Austin, TX 78705 Phone: 512-324-3580 Fax: 512-324-3581 | |
Dr. Robert Lee, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-544-7111 | |
Dr. Lori Beth Wasserburger, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2525 Wallingwood Dr, Bldg 1, Ste 212, Austin, TX 78746 Phone: 512-358-0500 Fax: 512-358-0520 | |
Faheem Mahomed, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1601 Trinity St, Austin, TX 78712 Phone: 512-913-5011 | |
Darius N. Clarke, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 823 Congress Ave Ste 150-518, Austin, TX 78701 Phone: 888-380-0988 Fax: 289-236-3022 | |
Joseph A. Volpe, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 12221 N Mopac Expy, Austin, TX 78758 Phone: 512-901-4011 Fax: 512-901-3950 |